Healthcare

Vitamin D Therapy Global Market 2024 – By Size, Share, Trends, Demand, Forecast To 2033 | Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC

The vitamin d therapy market size is expected to see rapid growth in the next few years. It will grow to $4.8 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to continued awareness and education, rising geriatric population, integration of vitamin d in chronic disease management, technological advances in formulations, global health initiatives, increased focus on personalized nutrition. Major trends in the forecast period include expanding applications beyond bone health, government initiatives for supplementation, innovations in formulations and delivery methods, focus on clinical research and evidence-based practices, global market expansion.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report

Segmentation & Regional Insights
The vitamin d therapy market covered in this report is segmented –
1) By Administration: Oral, Parenteral
2) By Purchasing: OTC Drugs, Prescription Grugs
3) By Age Group: Children, Adults, Senior Adults
4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders

North America was the largest region in the vitamin D therapy market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin d therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp

Major Driver Impacting Market Growth
An increased prevalence of malnutrition cases is expected to propel the growth of the vitamin D therapy market going forward. Malnutrition refers to deficiencies or excesses in nutrient intake, imbalances of essential nutrients, or impaired nutrient utilization. Vitamin D deficiency is highly prevalent in the population of malnourished inpatients and is negatively associated with long-term mortality, particularly when patients are not receiving vitamin D treatment. Thus, the increased prevalence of malnutrition cases creates demand for vitamin D therapy. For instance, in June 2021, according to an article by the World Health Organization, a Switzerland-based agency working to promote health, keep the world safe, and serve the vulnerable, around 1.9 billion adults are overweight or obese, while 462 million are underweight globally in 2020, And around 149 million children under 5 were estimated to be stunted, 45 million were estimated to be wasted, and 38.9 million were overweight or obese. Therefore, the increasing prevalence of malnutrition cases is driving the growth of the vitamin D therapy market.

Key Industry Players
Major companies operating in the vitamin d therapy market report are Abbott Laboratories, Sanofi SA, GlaxoSmithKline plc, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.

The vitamin d therapy market report table of contents includes:
1. Executive Summary
2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Characteristics
3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends And Strategies
4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market – Macro Economic Scenario
5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and Growth
…………………..
31. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Benchmarking
32. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market
34. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Good PR News